KORELASI KADAR FERRITIN DENGAN KADAR BRAIN DERIVED NEUROTROPIC FACTOR (BDNF) PADA PREEKLAMSIA
| dc.contributor.advisor | Ariadi, Ariadi | |
| dc.contributor.author | Dona, Mirsa Putri | |
| dc.date.accessioned | 2026-09-24T23:13:49Z | |
| dc.date.issued | 2020-11-02 | |
| dc.description | Dr.dr. H. Ariadi, Sp.OG | |
| dc.description.abstract | Background and Objective: Iron deficiency anemia that followed by low serum ferritin levels in early pregnancy has an indirect impact on decreasing the expression of Brain Derived Neurotrophic Factor (BDNF) in the maternal hippocampus. BDNF together with its receptor tyrosine kinase B (TrkB) induced the expression of metalloproteinase-9 (MMP-9) which plays an important role in blastocyst implantation, trophoblast invasion and placental development. Decreasing BDNF levels can interfere with those process which caused imbalance of pro-angiogenic and anti-angiogenic factors such as VEGF, PIGF, sFlt1 and sEng that leads to preeclampsia. This study aims to determine the correlation between ferritin and BDNF serum levels in preeclampsia. Methods: This was an observasiotnal study with a cross-sectional design involving above 20 term pregnant women who were diagnosed with preeclampsia. A total of 66 sample were taken from Dr. M. Djamil Padang Hospital and examined for ferritin and BDNF serum levels using the ELISA method. The data normality test was performed using the Kolmogorov-Smirnov test, followed by the Pearson correlation test and simple linear regression test. Result: Ferritin serum level was normal (181.76 ± 212.08 ng/ml). The mean of BDNF levels were found to be lower than normal pregnancies (0.505 ± 0.314 ng/ml) (normal range of BDNF levels was 8-46 ng/ml). There was an insignificant positive correlation between ferritin levels and serum BDNF levels, with correlation coefficient (R) 0.147 (weak correlation) (p = 0.240). Conclusion: Ferritin serum level have positive correlation with BDNF serum level in preeclampsia. | |
| dc.identifier.uri | https://ailib.my.id/handle/123456789/71031 | |
| dc.language.iso | id | |
| dc.publisher | Universitas Andalas | |
| dc.subject | Preeklamsia | |
| dc.subject | ferritin | |
| dc.subject | anemia defisiensi besi | |
| dc.subject | Brain Derived Neurotrophic Factor | |
| dc.subject.classification | RG Gynecology and obstetrics | |
| dc.title | KORELASI KADAR FERRITIN DENGAN KADAR BRAIN DERIVED NEUROTROPIC FACTOR (BDNF) PADA PREEKLAMSIA | |
| dc.type | Thesis | |
| dcterms.dateSubmitted | 2021-07-21 | |
| dcterms.references | DAFTAR PUSTAKA 1. World Health Organization. Maternal Mortality. Fact Sheet. 2019. 2. Kementerian Kesehatan Republik Indonesia. Profil Kesehatan Indonesia. Jakarta: Kementerin Kesehatan RI. 2019 3. Rana Sarosh, et al. Compendium of Pathophysiology and Treatment of Hipertension, Preeclampsia: Pathophysiology, Challenges, and Perspektive. AHA Journals. 2020. 4. American College of Obstetricians and Gynecologists. Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013;122:1122–1131. 5. Canadian Hypertensive Disorders of Pregnancy Working Group, Diagnosis, Evaluation, and Management of the Hypertensive Disorders of Pregnancy: Executive Summary. Journal of Obstetrics Gynecology Canada. 2014: 36(5); 416-438. 6. Einarsson JI, Sangi-Haghpeykar H, Gardner NO. Sperm exposure and development of preeclampsia. Am J Obstet Gynecol. 2003;188:1241-3. 7. Sibai BM, Hauth J, Caritis S, Lindheimer MD, MacPherson C, Klebanoff M, et al. Hypertensive disorders in twin versus singleton gestations. Am J Obstet Gynecol 2000;182:938-42. 8. Perkumpulan Obstetri dan Ginekologi Indoensia. Pedoman Nasional Pelayanan Kedokteran: Diagnosis dan Tatalaksana Preeclampsia. Jakarta: POGI Himpunan Kedokteran Fetomaternal: 2016. 9. Sibai Baha, Dekker Gus, Kupferminc Michael, 2005. Preeclampsia, Lancet: 365: 785-99. 10. Cunningham L, Bloom, Dashe. Hypertensive Disorders. Williams Obstetric 25 ed. New York: Mc Graw Hill; 2018. p.1086-40 11. Belammy L, Casas JP, Hingorani AD, Williams DJ. Preeclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ. 2007;335:974. 12. Kaur, M., Chauhan, A., Manzar, M. D., & Rajput, M. M. (2015). Maternal Anaemia and Neonatal Outcome: A Prospective Study on Urban Pregnant Women. Journal of clinical and diagnostic research: JCDR, 9(12), QC04. 13. World Health Organization. Iron Deficiency Anaemia Assessment, Prevention, and Control: A guide for programme managers. 14. Ali AA, et al. Severe anaemia is associated with a higher risk for preeclampsia and poor perinatal outcomes in Kassala hospital, eastern Sudan. BMC Research Notes. 2011, 4:311. 15. Rohilla M., Ravveendran.A., Dhaliwal.L.K. 2010. Severe Anaemia in Pregnancy a Tertiary Hospital Experience from Northern India. Journal of Obstertrics and Gynaecology 30:694-696. 16. Enaruna NO, Sodje JD. Early-Onset Severe Preeclampsia in Nigerian Women: Determining a Balance between Maternal Wellbeing and Fetal Survival in a Resource-Limited Setting. British J Med Med Res. 2015;10(3):1-9. 17. Bathina et al. Brain-derived neurotrophic factor and its clinical implications. Arch Med Sci 2015; 11, 6: 1164–1178 18. Kawamura et al. Brain-Derived Neurotrophic Factor Promotes Implantation and Subsequent Placental Development by Stimulating Trophoblast Cell Growth and Survival. Endocrinology. 2009, 150(8):3774–3782 19. Zhu JY et al. Regulation of Trophoblast Invasion: The Role of Matrix Metalloproteinases. Rev Obstet Gynecol. 2012;5(3/4):e137 e143. 20. Lee R, P. Kermani, K.K. Teng, B.L. Hempstead. Regulation of cell survival by secreted proneurotropins, Science 2001, 294 (5548). 21. Roux PP, Barker PA, 2002. Neurotropin signaling through the P75 neurotropin receptor. Prog Neurobiol.; 67(3):203-33. 22. Antonella Papa, 2014. Analisi funzionale dei recettori per le neurotropine P75NTR dan Trka in neuroblastoma. https://www.researchgate.net /publication/46091449. 23. Tran et al. Early-Life Iron Deficiency Anemia Alters Neurotrophic Factor Expression and Hippocampal Neuron Differentiation in Male Rats. J. Nutr. 138: 2495–2501, 2008. 24. Estrada et al. Molecular mechanisms of cognitive impairment in iron deficiency: Alterations in brain-derived neurotrophic factor and Insulinlike growth factor expression and function in the central nervous system. Nutritional Neuroscience 2014 Vol. 17 No. 5. Hh 193-206. 25. Tran et al. Long-Term Reduction of Hippocampal Brain-Derived Neurotrophic Factor Activity After Fetal-Neonatal Iron Deficiency in Adult Rats. Pediatric Research. 2009. Vol. 65, No. 5. 26. Sara M, et al. Iron administration prevents BDNF decrease and depressive-like behavior following chronic stress. J brainres. 2014.10.057. 27. Flora et al. Correlation Between Brain-Derived Neurotrophic Factor Levels and Serum Iron Levels in Stunted Children Living in Malaria-Endemic Areas. Journal of Medical Sciences. 2020 May 10; 8(E):318-321 28. Raymond D, Peterson E. A critical review of early-onset and late-onset preeklampsia. Obstet Gynecol Surv. 2011 Aug;66(8):497-506. doi: 10.1097/OGX.0b013e3182331028. 29. Elizabeth Phipps, Devika Prasanna, Wunnie Brima, Belinda Jim. Preeklampsia: Updates in Pathogenesis, Definitions and Guidelines. Clin J Am Soc Nephrol 11: 1102–1113, 2016. doi: 10.2215/CJN.12081115 30. Gao Q, Tang J, Li N, Liu B, Zhang M, Sun M, et al. What is precise pathophysiology in development of hypertension in pregnancy. Precision medicine requires precise physiology and pathophysiology. Drug discovery today. 2018;23(2):286-99. 31. Tai-Ho Hung, Graham J. Burton. Hypoxia And Reoxygenation: A Possible Mechanism For Placental Oxidative Stress In Preeklampsia . Taiwanese J Obstet Gynecol 2006 .Vol 45, No 3. 32. Lita Nafratilova, Yusrawati , Irza Wahid, 2018. Differences in levelFms-Like Tyrosine Kinase-1 (sFlt-1), soluble Endoglin (s-Eng), and Placental Growth Factor (PIGF) between Early Onset Preeklampsia and Late Onset Preeklampsia. Journal of Midwifery Vol 3: No 2. 33. Murray et al. An Overview of Brain-Derived Neurotrophic Factor and Implications for Excitotoxic Vulnerability in the Hippocampus. International Journal of Peptides. 2011. Vol 01. Hh 1-12. 34. Binder et al. Brain-derived Neurotrophic Factor. Growth Factors. 2004 September; 22(3): 123–13. 35. Miranda et al. Brain-Derived Neurotrophic Factor: A Key Molecule for Memory in the Healthy and the Pathological Brain. Frontiers in Cellular Neuroscience. 2019. 13:363. 36. Desby Juananda, Dwi Cahyani Ratna Sari, Djoko Prakos, Nur Arfian, Mansyur Romi. Pengaruh Stres Kronik terhadap Otak: Kajian Biomolekuler Hormon Glukokortikoid dan Regulasi Brain-Derived Neurotrophic Factor (BDNF) Pascastres di Cerebellum. JIK 2015. Jilid 9, Nomor 2: Hal. 65-70. 37. Lisa M. Christian, Amanda M. Mitchell, Shannon L. Gillespie, and Marilly Palettas. Serum brain-derived neurotrophic factor (BDNF) across pregnancy and postpartum: Associations with race, depressive symptoms, and low birth weight. Psychoneuroendocrinology. 2016 December ; 74: 69–76. doi:10.1016/j.psyneuen.2016.08.025 38. Cunningham F, Leveno K, Bloom S, Hauth J, Rouse D, Spong C, et al. Pregnancy Hypertension. William Obstetrics, edisi ke-24. New York: McGraw-Hill, 2010 : 706-756. 39. Tranquilli AL, Dekker G, Magee L, Roberts J, Sibai BM, Steyn W, Zeeman GG, Brown MA. The classification, diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISSHP. Pregnancy Hypertension: An International Journal of Women;s Cardiovascular Health 2014: 4(2):99-104. 40. Elizabeth Phipps, Devika Prasanna, Wunnie Brima, Belinda Jim. Preeclampsia: Updates in Pathogenesis, Definitions and Guidelines. Clin J Am Soc Nephrol 11: 1102–1113, 2016. 41. Chappell LC, Enve S, Seed P, Briley Pregnancy, Lucilla Poston, Shennan AH. Adverse Perinatal Outcomes and Risk Factors for Preeclampsia in Women With Chronic Hypertension: A Prospective Study. Hypertension. 2008; 51: 1002-1009. 42. Ayunani et al. Faktor Ibu, Janin dan Riwayat Penyakit sebagai Risiko Preeklampsia di Asia dan Afrika: Suatu Meta-Analisis. Jurnal Kesehatan Reproduksi, 10(2), 2019:127-139. 43. Lowa SA et al. Guideline for the management of hypertensive disorders of pregnancy. Somanz Journal. 2014, Vol. 01. Hh 1-50. 44. Nursal, Dien GA, Pratiwi Tamela, Fitrayeni. Faktor Risiko Kejadian Preeklampsia pada Ibu Hamil di RSUP DR. M. Djamil Padang Tahun 2014. 2015;2014:38–44. 45. Atjo, S., Bahrun, U. & Hardjoeno. Analisis Kadar Serum Feritin di Karsinoma Payudara. Indones. J. Clin. Pathol. Med. Lab. 22, 34–37 (2015). 46. Moglia, I., Santiago, M., Soler, M. & Olivera-Nappa, A. Silver nanoparticle synthesis in human ferritin by photochemical reduction. J. Inorg. Biochem. 206, 111016 (2020). 47. Chen, Y., Hu, Y., Chen, H., Li, X. & Qian, P. A ferritin nanoparticle vaccine for foot-and-mouth disease virus elicited partial protection in mice. Vaccine 38, 5647–5652 (2020). 48. Bitonto, V. et al. L-ferritin: A theranostic agent of natural origin for MRI visualization and treatment of breast cancer. J. Control. Release 319, 300–310 (2020). 49. Wei Wang, Mary Ann Knovich, Lan G. Coffman, Frank M. Torti, S. V. T. Serum Ferritin: Past, Present and Future. Bone 23, 1–7 (2013). 50. Palombarini, F., Ghirga, F., Boffi, A., Macone, A. & Bonamore, A. Application of crossflow ultrafiltration for scaling up the purification of a recombinant ferritin. Protein Expr. Purif. 163, 4–7 (2019). 51. Raden Tina Dewi Judistiani Mochamad Ari Wibowo, Adhi K Sugianli, D. P. Kecukupan Asupan Zat Besi Dan Protein Pada Ibu Hamil Trimester 1 : Masihkah Berkaitan Dengan Kadar Ferritin Serum. (2018). 52. Worwood, M. Annex 2: Indicators of the iron status of populations: ferritin. Assess. iron status Popul. 35–74 (2007). 53. Loho, I. K. A., Rambert, G. I. & Wowor, M. F. Gambaran kadar ureum pada pasien penyakit ginjal kronik stadium 5 non dialisis. J. e-Biomedik 4, (2016). 54. WHO. Serum ferritin concentrations for the assessment of iron status and iron deficiency in populations. Vitamin and Mineral Nutrition Information System. Who 1–5 (2011) doi:(WHO/NMH/NHD/MNM/11.2). 55. Ferreira C, Bucchini D, Martin ME, et al. Early embryonic lethality of H ferritin gene deletion in mice. J Biol Chem. 2000;275:3021-3024 56. Jacobs A, Worwood M. Ferritin in Serum Clinical and Biochemical Implications. The New England Journal of Medicine, 1975, 292; 18: 951-6. 57. Morrison JC. Anemia Associated with Pregnancy. In: Sciarra JJ (Ed) Gynecology and Obstetrics, Vol 3, Harper & Row Publisher, Philadelphia, 1983, 16: 1-18. 58. Erslev AJ. Anemia of Chronic Disorders. In: Williams WJ (Ed). Hematology. Fourth Edition, International Edition, Mc Graw Hill Publishing Company, New York. 1991: 540-44. 59. Scholl OT. Iron Status during Pregnancy: setting the stage for mother and infant. Am J Clin Nutr 2005;81:1218-22. 60. Andrews SC, Arosio P, Bottke B, Briat JF, VonDarl M, Harrison PM, et al. Structure, function, and evolution of ferritins. J Inorg Biochem 1992;47:161- 74. 61. Harrison PM, Arosio P. The ferritins: molecular properties, iron storage function and cellular regulation. Biochym Biophys Acta 1996;1275:161-203. 62. Levi S, Santambrugio P, Corsi B, Cozzi A, Arosio P. Evidence that residues exposed on the threefold channels have active roles in the mechanism of ferritin iron incorporation. Biochem J 1996;317:467-73. 63. Nemanja v et al. Blood ferritin levels in pregnant Women and prediction of the development of fetal intrauterine growth restriction. Journal of Medical Biochemistry. 2011; (30)4. 64. Asif N, Hassan K, Mahmud S, et al. Comparison of Serum Ferritin Levels in Three Trimesters of Pregnancy and Their Correlation with Increasing Gravidity, International Journal of Pathology, 2008,5(1): 26-30. 65. Khalambia et al. High maternal serum ferritin in early pregnancy and risk of spontaneous preterm birth. British Journal of Nutrition.Vol 144 (3). 66. Odiegwu CNC et al. Comparative studies of serum ferritin and anemia status in the sthree stages of gestation. Journal of Haematology and Thromboembolic disease. 2018; (6)2. 67. Cheepsunthorn P, Palmer C, Menzies S, Roberts RL, Connor JR. Hypoxic/ischemic insult alters ferritin expression and myelination in neonatal rat brains. J Comp Neurol. 2001;431:382-396. 68. Chi SI, Wang CK, Chen JJ, Chau LY, Lin TN. Differential regulation of H- and L-ferritin messenges RNA subunits, ferritin protein and iron following focal cerebral ischemia-reperfusion. Neuroscience. 2000;100:475-484. 69. Pang JH, Jiang MJ, Chen YL, et al. Increased ferritin gene expression in atherosclerotic lesions. J Clin Invest. 1996;97:2204-2212. 70. Picard V, Epsztejn S, Santambrogio P, Cabantchik ZI, Beaumont C. Role of ferritin in the control of the labile iron pool in murine erythroleukemia cells. J Biol Chem. 1998;273:15382-15386. 71. Konijn AM, Glickstein H, Vaisman B, MeyronHoltz EG, Slotki IN, Cabantchik ZI. The cellular labile iron pool and intracellular ferritin in K562 cells. Blood. 1999;94:2128-2134. 72. Eisenstein RS, Garcia-Mayol D, Pettingell W, Munro HN. Regulation of ferritin and heme oxygenase synthesis in rat fibroblasts by different orms of iron. Proc Natl Acad Sci U S A. 1991;88: 688-692. 73. Balla G, Jacob HS, Balla J, et al. Ferritin: a cytoprotective antioxidant strategem of endothelium. J Biol Chem. 1992;267:18148-18153. 74. Cermak J, Balla J, Jacob HS, et al. Tumor cell heme uptake induces ferritin synthesis resulting in altered oxidant sensitivity: possible role in chemotherapy efficacy. Cancer Res. 1993;53:5308-5313. 75. Orino K, Tsuji Y, Torti FM, Torti SV. Adenovirus E1A blocks oxidant-dependent ferritin induction and sensitizes cells to pro-oxidant cytotoxicity. FEBS Lett. 1999;461:334-338. 76. Cozzi A, Corsi B, Levi S, Santambrogio P, Albertini A, Arosio P. Overexpression of wild type and mutated human ferritin H-chain in HeLa cells—in vivo role of ferritin ferroxidase activity. J Biol Chem. 2000;275:25122-25129. 77. Orino K, Lehman L, Tsuji Y, Ayaki H, Torti SV, Torti FM. Ferritin and the response to oxidative stress. Biochem J. 2001;357:241-247. 78. Epsztejn S, Glickstein H, Picard V, et al. H-ferritin subunit overexpression in erythroid cells reduces the oxidative stress response and induces multidrug resistance properties. Blood. 1999;94:3593-3603. 79. Tsuji Y, Ayaki H, Whitman SP, Morrow CS, Torti SV, Torti FM. Coordinate transcriptional and translational regulation of ferritin in response to oxidative stress. Mol Cell Biol. 2000;20:5818-5827. 80. Cairo G, Tacchini L, Pogliaghi G, Anzon E, Tomasi A, Bernelli-Zazzera A. Induction of ferritin synthesis by oxidative stress: transcriptional and post-transcriptional regulation by expansion of the “free” iron pool. J Biol Chem. 1995;270:700-703. 81. Cairo G, Castrusini E, Minotti G, Bernelli-Zazzera A. Superoxide and hydrogen peroxide-dependent inhibition of iron regulatory protein activity: a protective stratagem against oxidative injury. FASEB J. 1996;10:1326-1335. 82. Pantopoulos K, Hentze MW. Activation of iron regulatory protein-1 by oxidative stress in vitro. Proc Natl Acad Sci U S A. 1998;95:10559-10563. 83. Pantopoulos K, Hentze MW. Rapid responses to oxidative stress mediated by iron regulatory protein. EMBO J. 1995;14:2917-2924. 84. Kennedy MC, Antholine W, Beinert H. An EPR investigation of the products of the reaction of cytosolic and mitochodrial aconitases with nitric oxide. J Biol Chem. 1997;272:20340-20347. 85. Balla J, Jacob HS, Balla G, Nath K, Vercellotti GM. Endothelial cell heme oxygenase and ferritin induction by heme proteins: a possible mechanism limiting shock damage. Trans Assoc Am Physicians. 1992;105:1-6. 86. Tacchini L, Recalcati S, Bernelli-Zazzera A, Cairo G. Induction of ferritin synthesis in ischemicreperfused rat liver: analysis of the molecular mechanisms. Gastroenterology. 1997;113:946-953. 87. White K, Munro HN. Induction of ferritin subunit synthesis by iron is regulated at both the transcriptional and translational levels. J Biol Chem. 1988;263:8938-8942. 88. Rosen CF, Poon R, Drucker DJ. UVB radiationactivated genes induced by transcriptional and posttranscriptional mechanisms in rat keratinocytes. Am J Physiol Cell Physiol. 1995;37:C846–C855. 89. Applegate LA, Scaletta C, Panizzon R, Frenk E. Evidence that ferritin is UV inducible in human skin: part of a putative defense mechanism. J Invest Dermatol. 1998;111:159-163. 90. Gehring NH, Hentze MW, Pantopoulos K. Inactivation of both RNA binding and aconitase activities of iron regulatory protein-1 by quinoneinduced oxidative stress. J Biol Chem. 1999;274:6219-6225. 91. Ossola JO, Kristoff G, Tomaro ML. Heme oxygenase induction by menadione bisulfite adduct-generated oxidative stress in rat liver. Comp Biochem Physiol. 2000;127:91-99. 92. Mardiah et al. Perbedaan Kadar Brain Derived Neurotropic Factor Neonatus dari Ibu Hamil Normal dan Anemia Defisiensi Besi. Jurnal Endurance 3(3). Oktober 2018. Hh 568-574. 93. Yusrawati, Rina G, Indrawati LN. Differences in Brain-Derived Neurotrophic Factor Between Neonates Born to Mothers with Normal and Low Ferritin. Asia Pac J Clin Nutr. 2018;27(2):389-392. 94. Sara et al. Iron administration prevents BDNF decrease and depressive-like behavior following chronic stress. Brain Reasearch. 2014: 10. Hh 057 95. Flora et al. Correlation Between Brain-Derived Neurotrophic Factor Levels and Serum Iron Levels in Stunted Children Living in Malaria Endemic Areas. Journal of Medical Sciences. 2020 May 10; 8(E):318-321. 96. Wang et al. Preeklampsia: The Role of Angiogenic Factors in Its Pathogenesis. Physiol. 2009. 24: 147-158. 97. Tran et al. Fetal iron deficiency induces chromatin remodeling at the Bdnf locus in adult rat hippocampus. Am J Physiol Regul Integr Comp Physiol 2015. 308: R276 –R282. 98. Velicky P, Knoefler M and Polheimer J 2016. Function and Control of Human IVol. 13, No. 1nvasion Tropjoblast Subtypes: Intrinsic vs Maternal Control. Cell Adhesion and Migration, 2016, Vol 10, 154-162. 99. Moffett A and Colucci F. Uterine NK cells: active regulators at the maternal-fetal interface. J Clin Invest. 2014 May 1; 124(5): 1872–1879. 100. Soares MJ, Chakraborty D, Kubota K, Renaud SJ and Rumi MAK, 2014. Adaptive Mechanisms Controlling Uterine Spiral Artery Remodelling during the Establishment of Pregnancy. Int J Dev Biol. 2014; 58(0): 247–259. 101. Gupta SK, Malhotra SS, Malik A, Verma S and Chaudhary P, 2016. Cell signaling pathways involved during invasion and syncytialization of trophoblast cells. Am J Reprod Imunol. 2016; 75: 361-371. 102. Mendes S, Timoteo-Ferreira F, Almeida H and Silva E, 2019. New Insights into the Process of Placentation and the Role of Oxidative Uterine Microenvironment. Oxidative Medicine and Cellular Longevity, 2019. 103. Shayan et al. redictors of Preeclampsia Based on a 10-Year Case-Control Study. Journal of family and Reproductive Health. 2019. Vol. 13, No. 1. 104. Berek JS, Novak E. Berek and Novak's Gynecology: 15th ed. Lippincott Williams & Wilkins, 2012. 105. Magnus P, Eskild A. Seasonal variation in the occurrence of pre-eclampsia. BJOG 2001; 108:1116-9. 106. Tyas et al. Risk factor of severe preeclampsia in Dr. Soetomo Hospital Surabaya in 2015. Majalah Obstetri & Ginekologi, Vol. 25 No. 1 April 2017: 6-9. 107. Siveska J, Jasovic V, Stoilova, S. Previous Pregnancy history, parity, maternal age and risk of pregnancy induced hypertension. British Medical Journal. 2011;112(4):188-91. 108. Kartika et al. Riskfactor of severe preeclampsia in Dr. Soetomo Hospital Surabaya in 2015. Majalah Obstetri & Ginekologi, Vol. 25 No. 1 April 2017: 6-9. 109. Baker A, Haeri S. Estimating risk factors for development of preeclampsia in teen mothers. Archivesof Gynecology and Obstetrics. 2012;286(5):1093-1096. 110. Das et al. Incidence and Risk Factors of Pre-Eclampsia in the Paropakar Maternity and Women’s Hospital, Nepal: A Retrospective Study. Int. J. Environ. Res. Public Health 2019, 16, 3571. 111. Munawarah et al. Hubungan anatar preeklamsia dan anemia ibu hamil dengan berat bayi lahir rendah. Wellness and Healthy Megazine. 2019. Volume 1. No 02. P 157-167. 112. Sembiring et al. Pregnancy Induced Hypertension Accompanied With Anemia: Potential Stunting of Newborns. Global Journal of Health Science; Vol. 10, No. 6; 2018. 113. Lai et al. Systolic, Diastolic and Mean Arterial Pressure at 30–33 Weeks in the Prediction of Preeclampsia. 2013. Fetal Diagn Ther. p. 11015–3837. 114. Kumari et al. A Comparative Study of Blood Pressure in Normal and Pregnancy Induced Hypertensive Cases for Early Diagnosis of Hypertensive Disorders in A Tertiary Care Hospital. International Journal of Scientific Study. June 2014. Vol 2. Issue 3. 115. Denantika O, Serudji J, Revilla G. 2015. Hubungan Status Gravida dan Usia Ibu terhadap Kejadian Preeklampsia di RSUP Dr. M. Djamil Padang Tahun 2012-2013. Jurnal Kesehatan Andalas 4(1). 116. Sahay A.S, D.P. Sundrani, G.N. Wagh, S.S. Mehendale , S.R. Joshi. Neurotropin levels in different regions of the placenta and their association with birth outcome and blood pressure. 2015. http://dx.doi.org/10.1016/j.placenta.2015.06.006. Elsevier. 117. El Shahat AM, Ahmed AB, Ahmed MR, Mohamed HS. 2013. Maternal serum leptin as a marker of preeklampsia. Arch Gynecol Obstet 288(6):1317-1322. 118. D’Souzaa, Vidya Patila, Hemlata Pisala, Karuna Randhira, Asmita Joshia, Savita Mehendaleb, Girija Waghb, Sanjay Guptec, Sadhana Joshia, 2014. Levels of brain derived neurotrophic factors across gestation inwomen with preeklampsia. Int. J. Devl Neuroscience 37. Hal 36–40. 119. M. Dhobale. Neurotrophic Factors and Maternal Nutrition During Pregnanc. BioTRaK Research and Diagnostics Centre, Navi Mumbai, India.Elsevier, 2017. Volume 104, ISSN 0083-6729. 120. Perucci LO, Vieira ELM, Teixeira AL, Gomes KB, Dusse LM, Sousa LP. Decreased plasma concentrations of brain-derived neurotrophic factor in preeklampsia Clinica Chimica Acta 2017;464:142-7. 121. Mannaerts D, Faes E, Cos P, Briede ´ JJ, Gyselaers W, Cornette J, et al. (2018) Oxidative stress in healthy pregnancy and preeclampsia is linked to chronic inflammation, iron status and vascular function. PLoS ONE 13(9): e0202919. 122. Paul R, et al. Association between serum ferritin and preeclampsia. Bangladesh Med J. 2018 Sept; 47(3). 123. Gutierrez-Aguirre CS et al. Comparartive analysis of iron status and other hematological parameters in preeclampsia. Hematology, 2017; 22:1, 36-40. 124. Laila, et al. Serum ferritin in preeclampsia and eclampsia: a case control study. Faridpur med coll journal. 2013; 8(1): 18-21. 125. Yesmin et al. Evaluation of serum ferritin concentration in mild and severe preeclamptic woman. Mymensingh med J. 2016. (1):119-25. 126. Aljafar et al. HWA: Hypoferritinemia without anemia a hidden hematology disorder. J Family Med Prim Care. 2017 Jan-Mar; 6(1): 69–72. 127. Cunningham, FG. Protocols for High-Risk Pregnancies: An Evidence-Based Approach. Fifth Edition. Dallas:2010. 128. Metelli G, Polacchini A. A method for reproducible measurements of serum BDNF: comparison of the performance of six commersial assays. Scientific Reports. 2015. 5: 17988. | |
| local.eprints.dir | disk0/00/07/79/39 | |
| local.eprints.division | S2 | |
| local.eprints.id | 77939 | |
| local.eprints.type | thesis/masters | |
| local.eprints.uri | http://scholar.unand.ac.id/77939/ | |
| local.fakultas | Pascasarjana (S2) | |
| local.thesis.level | Tesis |
